Medicare AdvantageCoverageMedium impact
MA00.002t, Continuous Glucose Monitors and Home Blood Glucose Monitors and Supplies
Independence Blue Cross·Endocrinology, Internal Medicine, Family Medicine +1 more·Medical Policy
Effective date
Oct 5, 2026
We identified it
Sep 5, 2026
Summary
Policy MA00.002t regarding Continuous Glucose Monitors and Home Blood Glucose Monitors and Supplies has been updated. This is a coverage and/or reimbursement position change with general description, guidelines, or informational updates. The billing team must review the full policy text to identify specific coverage criteria, billing code changes, or reimbursement adjustments effective October 5, 2026.
Action Required
By October 5, 2026: Billing team must obtain and review the complete policy text at https://medpolicy.ibx.com/ibc/ma/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=09&FilterField2=MPSiteActivityLogYear&FilterValue2=2026#medicare-advantage-ma00-002t-continuous-glucose-monitors-and to identify specific HCPCS codes for glucose monitors and supplies, any prior authorization requirements, and updated reimbursement rates. Update billing system rules, encounter forms, and staff training materials accordingly. Flag all continuous glucose monitor and home blood glucose monitor claims for compliance review during the transition period. Without timely policy implementation, claims may be denied or incorrectly processed.